[go: up one dir, main page]

DE69932113D1 - Pharmazeutische Zusammensetzungen von Hedgehog-Proteinen und deren Verwendung - Google Patents

Pharmazeutische Zusammensetzungen von Hedgehog-Proteinen und deren Verwendung

Info

Publication number
DE69932113D1
DE69932113D1 DE69932113T DE69932113T DE69932113D1 DE 69932113 D1 DE69932113 D1 DE 69932113D1 DE 69932113 T DE69932113 T DE 69932113T DE 69932113 T DE69932113 T DE 69932113T DE 69932113 D1 DE69932113 D1 DE 69932113D1
Authority
DE
Germany
Prior art keywords
carrier
hedgehog protein
hedgehog
negatively
binds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69932113T
Other languages
English (en)
Other versions
DE69932113T2 (de
Inventor
Kurt Lang
Apollon Papadimitriou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Curis Inc
Original Assignee
Curis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Curis Inc filed Critical Curis Inc
Publication of DE69932113D1 publication Critical patent/DE69932113D1/de
Application granted granted Critical
Publication of DE69932113T2 publication Critical patent/DE69932113T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69932113T 1998-02-04 1999-02-04 Pharmazeutische Zusammensetzungen von Hedgehog-Proteinen und deren Verwendung Expired - Fee Related DE69932113T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP98101893 1998-02-04
EP98101893 1998-02-04
EP98104416 1998-03-12
EP98104416 1998-03-12

Publications (2)

Publication Number Publication Date
DE69932113D1 true DE69932113D1 (de) 2006-08-10
DE69932113T2 DE69932113T2 (de) 2007-01-25

Family

ID=26149005

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69932113T Expired - Fee Related DE69932113T2 (de) 1998-02-04 1999-02-04 Pharmazeutische Zusammensetzungen von Hedgehog-Proteinen und deren Verwendung

Country Status (14)

Country Link
JP (1) JP3092706B2 (de)
KR (2) KR19990072406A (de)
CN (1) CN1228994A (de)
AT (1) ATE331533T1 (de)
AU (1) AU713568B2 (de)
CA (1) CA2260423C (de)
CZ (1) CZ33799A3 (de)
DE (1) DE69932113T2 (de)
HU (1) HUP9900251A3 (de)
IL (1) IL128329A (de)
MA (1) MA26602A1 (de)
NO (1) NO990471L (de)
NZ (1) NZ334065A (de)
SG (1) SG66504A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW570805B (en) 1998-09-01 2004-01-11 Hoffmann La Roche Water-soluble pharmaceutical composition in an ionic complex
KR100452752B1 (ko) * 2000-04-18 2004-10-12 주식회사 펩트론 단백질 함유 서방성 제제를 제조하는 방법 및 그 제제
KR101705323B1 (ko) * 2010-03-23 2017-02-13 코웨이 주식회사 역삼투막 방식의 정수기
KR102176832B1 (ko) * 2017-11-29 2020-11-10 주식회사 파이안바이오테크놀로지 헤지호그 단백질 및 생체 적합성 물질을 포함하는 미세 입자 및 이를 포함하는 탈모 예방 또는 치료용 조성물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5866165A (en) 1997-01-15 1999-02-02 Orquest, Inc. Collagen-polysaccharide matrix for bone and cartilage repair

Also Published As

Publication number Publication date
ATE331533T1 (de) 2006-07-15
CN1228994A (zh) 1999-09-22
AU713568B2 (en) 1999-12-02
DE69932113T2 (de) 2007-01-25
AU1542699A (en) 1999-08-26
IL128329A (en) 2005-08-31
SG66504A1 (en) 2000-07-18
NO990471L (no) 1999-08-05
MA26602A1 (fr) 2004-12-20
HUP9900251A3 (en) 2001-01-29
JP2000119193A (ja) 2000-04-25
KR19990072406A (ko) 1999-09-27
CA2260423A1 (en) 1999-08-04
CZ33799A3 (cs) 1999-08-11
IL128329A0 (en) 2000-01-31
NZ334065A (en) 2000-06-23
KR19990072423A (ko) 1999-09-27
HU9900251D0 (en) 1999-03-29
CA2260423C (en) 2006-06-20
KR100311565B1 (ko) 2001-11-02
HUP9900251A2 (hu) 1999-09-28
NO990471D0 (no) 1999-02-01
JP3092706B2 (ja) 2000-09-25

Similar Documents

Publication Publication Date Title
ATE252919T1 (de) Zusammensetzungen und ihre verwendung zur verhütung von verklebungen zwischen körpergewebe
CA2291074A1 (en) Composition and method for enhancing transport across biological membranes
CA2239775A1 (en) Crosslinked polymer compositions and methods for their use
CA2371462A1 (en) Modified protein matrices
PT814827E (pt) Factor de crescimento vascular endotelial-b
TR200101751T2 (tr) Poliol-IFN-beta konjugatları
AU3822497A (en) Temperature sensitive gel for sustained delivery of protein drugs
AR014940A1 (es) Un portador para la liberacion de un agente bioactivo, un polimero poliester biodegradable, copolimeros y composiciones farmaceuticas que loscontienen.
ATE332918T1 (de) Neoglycoproteine
WO2004032862A3 (en) Cyclodextrin-based materials, compositions and uses related thereto
CA2251281A1 (en) Drug composition with controlled drug release rate
ATE267854T1 (de) Materialen aus polymermischungen auf basis von zwitterionischem polymer
DE60334388D1 (de) Blockcopolymer-mizellenzusammensetzung mit verbesserter arzneimittelbeladungskapazität und verzögerter freisetzung
CA2287534A1 (en) Biodegradable microparticles for the sustained delivery of therapeutic drugs
ATE331533T1 (de) Pharmazeutische zusammensetzungen von hedgehog- proteinen und deren verwendung
ES2167939T3 (es) Nuevas poliaminas, su preparacion y usos.
CO4810246A1 (es) Polipeptidos modificados con alta actividad y alergenicidad reducida
WO1996028468A3 (en) Amphiphilic peptide and analogs thereof
WO1990007321A3 (en) Lymphocyte receptor homing sequences and their uses
WO1991003226A3 (en) Pharmaceutical compositions containing aromatic polymers and therapeutic methods using the same
EP0354714A3 (de) Polyaromatische Verbindungen enthaltende pharmazeutische Zusammensetzungen
CY1111004T1 (el) Χρησιμες συνθεσεις για τη ρυθμιση της δρασης του γονιδιου της παρκινης
ECSP992851A (es) Composiciones farmaceuticas de proteinas erizo y uso de las mismas
AR014530A1 (es) Composicion farmaceutica de proteinas ''erizo'' y un procedimiento para su produccion
DE69608644D1 (de) Dispersions- oder Auftragungsverfahren eines aktiven Materials, Zusammensetzung und Gemäss diesem Verfahren hergestelltes Geschoss

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee